Iain J. Abbott

1.7k total citations
41 papers, 995 citations indexed

About

Iain J. Abbott is a scholar working on Epidemiology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Iain J. Abbott has authored 41 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 18 papers in Molecular Medicine and 10 papers in Infectious Diseases. Recurrent topics in Iain J. Abbott's work include Antibiotic Resistance in Bacteria (18 papers), Urinary Tract Infections Management (16 papers) and Bacterial Identification and Susceptibility Testing (10 papers). Iain J. Abbott is often cited by papers focused on Antibiotic Resistance in Bacteria (18 papers), Urinary Tract Infections Management (16 papers) and Bacterial Identification and Susceptibility Testing (10 papers). Iain J. Abbott collaborates with scholars based in Australia, Greece and Netherlands. Iain J. Abbott's co-authors include Anton Y. Peleg, Andrew J. Stewardson, Gustavo M. Cerqueira, Md Saruar Bhuiyan, Bradley J. Gardiner, Kelly A. Cairns, Jason A. Roberts, Joseph Meletiadis, Johan W. Mouton and Michael Dooley and has published in prestigious journals such as Nature Communications, Clinical Microbiology Reviews and Clinical Infectious Diseases.

In The Last Decade

Iain J. Abbott

40 papers receiving 973 citations

Peers

Iain J. Abbott
Iain J. Abbott
Citations per year, relative to Iain J. Abbott Iain J. Abbott (= 1×) peers Ya‐Sung Yang

Countries citing papers authored by Iain J. Abbott

Since Specialization
Citations

This map shows the geographic impact of Iain J. Abbott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iain J. Abbott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iain J. Abbott more than expected).

Fields of papers citing papers by Iain J. Abbott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iain J. Abbott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iain J. Abbott. The network helps show where Iain J. Abbott may publish in the future.

Co-authorship network of co-authors of Iain J. Abbott

This figure shows the co-authorship network connecting the top 25 collaborators of Iain J. Abbott. A scholar is included among the top collaborators of Iain J. Abbott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iain J. Abbott. Iain J. Abbott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abbott, Iain J., et al.. (2025). Catheter-Associated Urinary Tract Infections: Understanding the Interplay Between Bacterial Biofilm and Antimicrobial Resistance. International Journal of Molecular Sciences. 26(18). 9193–9193.
2.
Abbott, Iain J., et al.. (2024). Oral ciprofloxacin biofilm activity in a catheter-associated urinary tract infection model. Journal of Antimicrobial Chemotherapy. 80(2). 413–426. 2 indexed citations
3.
Kostoulias, Xenia, Christina C. Chang, Jessica A. Wisniewski, et al.. (2023). Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia. Pathology. 55(5). 663–668. 3 indexed citations
4.
Abbott, Iain J., Kelly L. Wyres, Steven C. Wallis, et al.. (2022). Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model. Journal of Antimicrobial Chemotherapy. 77(5). 1324–1333. 10 indexed citations
5.
Abbott, Iain J., Nenad Maćešić, Steven C. Wallis, et al.. (2022). Oral ciprofloxacin activity against ceftriaxone-resistantEscherichia coliin anin vitrobladder infection model. Journal of Antimicrobial Chemotherapy. 78(2). 397–410. 3 indexed citations
6.
Gorrie, Claire L., Mirjana Mirčeta, Ryan R. Wick, et al.. (2022). Genomic dissection of Klebsiella pneumoniae infections in hospital patients reveals insights into an opportunistic pathogen. Nature Communications. 13(1). 3017–3017. 101 indexed citations
7.
Abbott, Iain J., Trisha Peel, Kelly A. Cairns, & Andrew J. Stewardson. (2022). Antibiotic management of urinary tract infections in the post-antibiotic era: a narrative review highlighting diagnostic and antimicrobial stewardship. Clinical Microbiology and Infection. 29(10). 1254–1266. 20 indexed citations
8.
Abbott, Iain J., Rixt A. Wijma, Joseph Meletiadis, et al.. (2020). Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic In Vitro Model. Antimicrobial Agents and Chemotherapy. 64(6). 24 indexed citations
9.
Abbott, Iain J., Jason A. Roberts, Joseph Meletiadis, & Anton Y. Peleg. (2020). Antimicrobial pharmacokinetics and preclinicalin vitromodels to support optimized treatment approaches for uncomplicated lower urinary tract infections. Expert Review of Anti-infective Therapy. 19(3). 271–295. 8 indexed citations
10.
Abbott, Iain J., Rixt A. Wijma, Joseph Meletiadis, et al.. (2020). Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against Enterobacterales : the Importance of Heteroresistance for Growth Outcome. Antimicrobial Agents and Chemotherapy. 64(3). 14 indexed citations
11.
Abbott, Iain J., et al.. (2020). Evaluation of pooled human urine and synthetic alternatives in a dynamic bladder infection in vitro model simulating oral fosfomycin therapy. Journal of Microbiological Methods. 171. 105861–105861. 18 indexed citations
12.
Wijma, Rixt A., Angela Huttner, Wendy Kloezen, et al.. (2019). Urinary antibacterial activity of fosfomycin and nitrofurantoin at registered dosages in healthy volunteers. International Journal of Antimicrobial Agents. 54(4). 435–441. 5 indexed citations
13.
Gardiner, Bradley J., Andrew J. Stewardson, Iain J. Abbott, & Anton Y. Peleg. (2019). Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems. Australian Prescriber. 42(1). 14–14. 103 indexed citations
14.
Maćešić, Nenad, Iain J. Abbott, Matthew Kaye, et al.. (2017). Herpes simplex virus‐2 transmission following solid organ transplantation: Donor‐derived infection and transplantation from prior organ recipients. Transplant Infectious Disease. 19(5). 12 indexed citations
15.
Abbott, Iain J., Joseph Meletiadis, Rixt A. Wijma, et al.. (2017). Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model. Journal of Antimicrobial Chemotherapy. 73(3). 709–719. 32 indexed citations
16.
Abbott, Iain J., Matthew Kaye, Helen Opdam, et al.. (2015). Laboratory Identification of Donor-Derived Coxsackievirus B3 Transmission. American Journal of Transplantation. 15(2). 555–559. 2 indexed citations
17.
Abbott, Iain J., Adam Jenney, Denis W. Spelman, et al.. (2015). Active surveillance for multidrug-resistant Gram-negative bacteria in the intensive care unit. Pathology. 47(6). 575–579. 8 indexed citations
18.
Abbott, Iain J., Gustavo M. Cerqueira, Md Saruar Bhuiyan, & Anton Y. Peleg. (2013). Carbapenem resistance inAcinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Review of Anti-infective Therapy. 11(4). 395–409. 117 indexed citations
19.
Abbott, Iain J., Monica A. Slavin, John Turnidge, Karin Thursky, & Leon J. Worth. (2011). Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. Expert Review of Anti-infective Therapy. 9(4). 471–488. 82 indexed citations
20.
Cuthbert, R, et al.. (1988). DDAVP shortens the bleeding time in bernard-soulier syndrome. Thrombosis Research. 49(6). 649–650. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026